leadf
logo-loader
viewBenchmark Holdings PLC

Benchmark Holdings directors shell out £600,000 on shares

Executive chairman Peter George dipped in for £470,000 and non-exec Yngve Myhre for another £135,240

Benchmark Holdings PLC - picture of shoal of fish
Conditions in the shrimp and seabass markets have been challenging in 2019

Two Benchmark Holdings PLC (LON:BMK) directors have shown their confidence in the aquaculture health company, dipping in for £0.6mln worth of shares. 

Executive chairman Peter George shelled out £470,000 to buy 1mln shares at a price of 47p apiece. 

He completed the purchase on Friday, Benchmark said in a statement on Monday, his first stake in the company.  

Yngve Myhre, the Norwegian aquaculture veteran who is a non-executive director of the company, also snapped up £135,240 worth of shares.

He scooped up 225,000 shares at 44.44p and another 75,000 at 46p, to take his total holding to 400,000 shares, or 0.07 of the company’s total share capital.

Last week Benchmark said it was accelerating a programme of disposals and structural efficiencies after discussions with third parties about licensing its non-core animal vaccines were subject to delays.

Quick facts: Benchmark Holdings PLC

Price: 44.5 GBX

AIM:BMK
Market: AIM
Market Cap: £297.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Benchmark Holdings PLC named herein, including the promotion by the Company of Benchmark Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Benchmark Holdings 'moving towards being a streamlined and profitable company'

Benchmark Holdings PLC's (LON:BMK) Trond Williksen and Septima Maguire caught up with Proactive to discuss its third quarter results. The firm posted positive earnings in the period, which it attributed to higher revenues and margins in its genetics division after moving external production...

2 weeks, 5 days ago

2 min read